161 related articles for article (PubMed ID: 20054600)
1. Low expression of chemokine receptor CCR5 in human colorectal cancer correlates with lymphatic dissemination and reduced CD8+ T-cell infiltration.
Zimmermann T; Moehler M; Gockel I; Sgourakis GG; Biesterfeld S; Müller M; Berger MR; Lang H; Galle PR; Schimanski CC
Int J Colorectal Dis; 2010 Apr; 25(4):417-24. PubMed ID: 20054600
[TBL] [Abstract][Full Text] [Related]
2. Expression of chemokine receptor CCR5 correlates with the presence of hepatic molecular metastases in K-ras positive human colorectal cancer.
Schimanski CC; Moehler M; Gockel I; Zimmermann T; Lang H; Galle PR; Berger MR
J Cancer Res Clin Oncol; 2011 Jul; 137(7):1139-45. PubMed ID: 21468700
[TBL] [Abstract][Full Text] [Related]
3. Selective infiltration of CCR5(+)CXCR3(+) T lymphocytes in human colorectal carcinoma.
Musha H; Ohtani H; Mizoi T; Kinouchi M; Nakayama T; Shiiba K; Miyagawa K; Nagura H; Yoshie O; Sasaki I
Int J Cancer; 2005 Oct; 116(6):949-56. PubMed ID: 15856455
[TBL] [Abstract][Full Text] [Related]
4. Active secretion of CXCL10 and CCL5 from colorectal cancer microenvironments associates with GranzymeB+ CD8+ T-cell infiltration.
Zumwalt TJ; Arnold M; Goel A; Boland CR
Oncotarget; 2015 Feb; 6(5):2981-91. PubMed ID: 25671296
[TBL] [Abstract][Full Text] [Related]
5. OX40 expression enhances the prognostic significance of CD8 positive lymphocyte infiltration in colorectal cancer.
Weixler B; Cremonesi E; Sorge R; Muraro MG; Delko T; Nebiker CA; Däster S; Governa V; Amicarella F; Soysal SD; Kettelhack C; von Holzen UW; Eppenberger-Castori S; Spagnoli GC; Oertli D; Iezzi G; Terracciano L; Tornillo L; Sconocchia G; Droeser RA
Oncotarget; 2015 Nov; 6(35):37588-99. PubMed ID: 26439988
[TBL] [Abstract][Full Text] [Related]
6. Tumor-derived chemokine CCL5 enhances TGF-β-mediated killing of CD8(+) T cells in colon cancer by T-regulatory cells.
Chang LY; Lin YC; Mahalingam J; Huang CT; Chen TW; Kang CW; Peng HM; Chu YY; Chiang JM; Dutta A; Day YJ; Chen TC; Yeh CT; Lin CY
Cancer Res; 2012 Mar; 72(5):1092-102. PubMed ID: 22282655
[TBL] [Abstract][Full Text] [Related]
7. Cytotoxic T-Cell Trafficking Chemokine Profiles Correlate With Defined Mucosal Microbial Communities in Colorectal Cancer.
Zhang J; Tao J; Gao RN; Wei ZY; He YS; Ren CY; Li QC; Liu YS; Wang KW; Yang G; Qian C; Chen JH
Front Immunol; 2021; 12():715559. PubMed ID: 34539647
[TBL] [Abstract][Full Text] [Related]
8. Pro-inflammatory chemokine-chemokine receptor interactions within the Ewing sarcoma microenvironment determine CD8(+) T-lymphocyte infiltration and affect tumour progression.
Berghuis D; Santos SJ; Baelde HJ; Taminiau AH; Egeler RM; Schilham MW; Hogendoorn PC; Lankester AC
J Pathol; 2011 Feb; 223(3):347-57. PubMed ID: 21171080
[TBL] [Abstract][Full Text] [Related]
9. The T-box transcription factor eomesodermin controls CD8 T cell activity and lymph node metastasis in human colorectal cancer.
Atreya I; Schimanski CC; Becker C; Wirtz S; Dornhoff H; Schnürer E; Berger MR; Galle PR; Herr W; Neurath MF
Gut; 2007 Nov; 56(11):1572-8. PubMed ID: 17566017
[TBL] [Abstract][Full Text] [Related]
10. Th17 cells inhibit CD8
Wang D; Yu W; Lian J; Wu Q; Liu S; Yang L; Li F; Huang L; Chen X; Zhang Z; Li A; Liu J; Sun Z; Wang J; Yuan W; Zhang Y
J Hematol Oncol; 2020 Jun; 13(1):68. PubMed ID: 32503584
[TBL] [Abstract][Full Text] [Related]
11. Tumor infiltrating lymphocytes: an intriguing player in the survival of colorectal cancer patients.
Deschoolmeester V; Baay M; Van Marck E; Weyler J; Vermeulen P; Lardon F; Vermorken JB
BMC Immunol; 2010 Apr; 11():19. PubMed ID: 20385003
[TBL] [Abstract][Full Text] [Related]
12. Opposing effects of CXCR3 and CCR5 deficiency on CD8+ T cell-mediated inflammation in the central nervous system of virus-infected mice.
de Lemos C; Christensen JE; Nansen A; Moos T; Lu B; Gerard C; Christensen JP; Thomsen AR
J Immunol; 2005 Aug; 175(3):1767-75. PubMed ID: 16034118
[TBL] [Abstract][Full Text] [Related]
13. Active participation of CCR5(+)CD8(+) T lymphocytes in the pathogenesis of liver injury in graft-versus-host disease.
Murai M; Yoneyama H; Harada A; Yi Z; Vestergaard C; Guo B; Suzuki K; Asakura H; Matsushima K
J Clin Invest; 1999 Jul; 104(1):49-57. PubMed ID: 10393698
[TBL] [Abstract][Full Text] [Related]
14. Expression of CCL5 (RANTES) and CCR5 in prostate cancer.
Vaday GG; Peehl DM; Kadam PA; Lawrence DM
Prostate; 2006 Feb; 66(2):124-34. PubMed ID: 16161154
[TBL] [Abstract][Full Text] [Related]
15. Effector memory T cells, early metastasis, and survival in colorectal cancer.
Pagès F; Berger A; Camus M; Sanchez-Cabo F; Costes A; Molidor R; Mlecnik B; Kirilovsky A; Nilsson M; Damotte D; Meatchi T; Bruneval P; Cugnenc PH; Trajanoski Z; Fridman WH; Galon J
N Engl J Med; 2005 Dec; 353(25):2654-66. PubMed ID: 16371631
[TBL] [Abstract][Full Text] [Related]
16. The effects of CCR5 inhibition on regulatory T-cell recruitment to colorectal cancer.
Ward ST; Li KK; Hepburn E; Weston CJ; Curbishley SM; Reynolds GM; Hejmadi RK; Bicknell R; Eksteen B; Ismail T; Rot A; Adams DH
Br J Cancer; 2015 Jan; 112(2):319-28. PubMed ID: 25405854
[TBL] [Abstract][Full Text] [Related]
17. Differential intracellular expression of CCR5 and chemokines in multiple sclerosis subtypes.
Jalonen TO; Pulkkinen K; Ukkonen M; Saarela M; Elovaara I
J Neurol; 2002 May; 249(5):576-83. PubMed ID: 12021948
[TBL] [Abstract][Full Text] [Related]
18. [Active immunity for anti-colorectal cancer induced by chemokine MCP-3 gene transfection].
Hu JY; Li GC; Zhu JG; Wang WM; Li YH; Zhou GH; Sun QB
Ai Zheng; 2002 May; 21(5):504-8. PubMed ID: 12452041
[TBL] [Abstract][Full Text] [Related]
19. The strength of the chemotactic response to a CCR5 binding chemokine is determined by the level of cell surface CCR5 density.
Desmetz C; Lin YL; Mettling C; Portalès P; Rabesandratana H; Clot J; Corbeau P
Immunology; 2006 Dec; 119(4):551-61. PubMed ID: 17177831
[TBL] [Abstract][Full Text] [Related]
20. Infiltrating CD8+ T cells in oral lichen planus predominantly express CCR5 and CXCR3 and carry respective chemokine ligands RANTES/CCL5 and IP-10/CXCL10 in their cytolytic granules: a potential self-recruiting mechanism.
Iijima W; Ohtani H; Nakayama T; Sugawara Y; Sato E; Nagura H; Yoshie O; Sasano T
Am J Pathol; 2003 Jul; 163(1):261-8. PubMed ID: 12819030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
